» Authors » Epifanio Ruiz

Epifanio Ruiz

Explore the profile of Epifanio Ruiz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 234
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jardim-Perassi B, Irrera P, Lau J, Budzevich M, Whelan C, Abrahams D, et al.
Contrast Media Mol Imaging . 2023 Jan; 2023():1944970. PMID: 36704211
The extracellular pH (pHe) of solid tumors is often acidic, as a consequence of the Warburg effect, and an altered metabolic state is often associated with malignancy. It has been...
2.
Russell S, Xu L, Kam Y, Abrahams D, Ordway B, Lopez A, et al.
BMC Biol . 2022 Jul; 20(1):163. PMID: 35840963
Introduction: Aggressive cancers commonly ferment glucose to lactic acid at high rates, even in the presence of oxygen. This is known as aerobic glycolysis, or the "Warburg Effect." It is...
3.
Jardim-Perassi B, Huang S, Dominguez-Viqueira W, Poleszczuk J, Budzevich M, Abdalah M, et al.
Cancer Res . 2019 Jun; 79(15):3952-3964. PMID: 31186232
It is well-recognized that solid tumors are genomically, anatomically, and physiologically heterogeneous. In general, more heterogeneous tumors have poorer outcomes, likely due to the increased probability of harboring therapy-resistant cells...
4.
Huang X, Pan Z, Doligalski M, Xiao X, Ruiz E, Budzevich M, et al.
Oncotarget . 2017 Feb; 8(29):46900-46914. PMID: 28159919
IDO1 is an enzyme catalyzing the initial and rate-limiting step in the catabolism of tryptophan along the kynurenine pathway. IDO1 expression could suppress immune responses by blocking T-lymphocyte proliferation locally,...
5.
Enriquez-Navas P, Kam Y, Das T, Hassan S, Silva A, Foroutan P, et al.
Sci Transl Med . 2016 Feb; 8(327):327ra24. PMID: 26912903
Conventional cancer treatment strategies assume that maximum patient benefit is achieved through maximum killing of tumor cells. However, by eliminating the therapy-sensitive population, this strategy accelerates emergence of resistant clones...
6.
Kam Y, Das T, Tian H, Foroutan P, Ruiz E, Martinez G, et al.
Int J Cancer . 2014 Aug; 136(4):E188-96. PMID: 25156304
ATP-binding cassette (ABC) drug transporters consuming ATPs for drug efflux is a common mechanism by which clinical cancers develop multidrug resistance (MDR). We hypothesized that MDR phenotypes could be suppressed...